Skip to content

Doctolib acquires Typeless to enhance AI capabilities in healthcare

Tech

24 June 2024

Doctolib, a leading European healthtech company based in Berlin, has announced the acquisition of Typeless, an EPFL spin-off specializing in AI speech recognition technology. Founded in 2022 by Matthieu Le Cauchois, Typeless uses advanced Large Language Models (LLM) to convert spoken language into structured text, reducing documentation efforts for medical staff.

Doctolib, a leading European healthtech company based in Berlin, has announced the acquisition of Typeless, an EPFL spin-off specializing in AI speech recognition technology.

Typeless‘ technology will be integrated into Doctolib‘s upcoming digital medical assistant, scheduled for release at the end of 2024. This integration aims to standardize doctor-patient conversations into clinical documentation, thereby freeing medical professionals from note-taking during consultations.

This acquisition is a strategic move by Doctolib to expand its AI capabilities, following its recent acquisition of Aaron.ai and the introduction of an AI-based telephone assistant. The Typeless team will enhance Doctolib’s expertise in data science, artificial intelligence, and robotics.

Reflecting on Typeless’ journey, the company expressed pride in developing medical speech-to-text and language technology that continues to serve an increasing number of healthcare practitioners. As a spin-off of the Idiap Research Institute, Typeless has benefited from substantial support through the BRIDGE Programme, as well as backing from Berkeley SkyDeck and EPFL.

Nikolay Kolev, Managing Director of Doctolib in Germany and member of the global Executive Board, stated, “The integration of Typeless and its team of experts is a further step in expanding our AI strategy. Following the recent acquisition of Aaron.ai, we are now reinforcing our commitment to support healthcare teams with leading technology to reduce their daily workload and give them more time to care for their patients.”

Matthieu Le Cauchois, Co-Founder and CEO of Typeless, added, “The opportunity to join Doctolib is an important step for our team. I am very excited that our technology will now help an even larger network of doctors and practice teams to save time when documenting conversations between doctors and patients.”

The partnership underscores Doctolib’s dedication to integrating cutting-edge AI technologies to improve healthcare efficiency and patient care. More information about the new medical assistant’s features will be announced as development progresses.